Developing analytical systems to characterize next-generation cancer immunotherapy
CellPly has raised $8.4M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in April 2026.
CellPly's investors include CDP Venture Capital, Indaco Venture Partners, LIFTT, EISMEA, Italian Angels for Growth.
CellPly is headquartered in Bologna, Italy.
Developing analytical systems to characterize next-generation cancer immunotherapy
CellPly is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"CellPly — Funding & Investors." VCBacked, April 23, 2026, https://www.vcbacked.co/company/cellply. Accessed October 16, 2026.
VCBacked. (2026). CellPly — Funding & Investors. Retrieved October 16, 2026, from https://www.vcbacked.co/company/cellply
{{cite web |title=CellPly — Funding & Investors |url=https://www.vcbacked.co/company/cellply |website=VCBacked |access-date=October 16, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated